Cognitive Training and Psilocybin for Alzheimer's Disease

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Recruiting Phase 2 Interventional Study
Alzheimer's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 – 120
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Other
Participants needed
200 (estimated)
Sponsor
National Institute on Aging (NIA) · NIH
Who this trial is looking for

This trial is looking for older adults aged 65 and over who have mild cognitive impairment or early-stage Alzheimer's disease, as well as healthy older adults. Participants will engage in brain training exercises and may take psilocybin, a compound found in certain mushrooms, to see how it can improve brain function.

Are You a Good Fit for This Trial?
Rules you out Severe mood disordersEpilepsyOther dementias

You may be able to join if

  • I am at least 65 years old
  • I can provide informed consent
  • I have early-stage Alzheimer's disease or mild cognitive impairment
  • I have no serious neuropsychiatric symptoms
  • I can take oral medication
  • I have a study partner to support me
  • I am willing to comply with all study procedures

You may not be able to join if

  • I have had a stroke or transient ischemic attack in the past year
  • I have a serious mental health condition like severe depression or PTSD
  • I have a history of epilepsy or other serious neurological disorders
  • I have had suicidal thoughts or behavior in the last 6 months
  • I have had a traumatic brain injury
  • I do not have a supportive study partner if I have early-stage Alzheimer's
  • I am pregnant or not using effective birth control
  • I have other types of dementia

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function. Objective:…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* Pending Web Eligibility
Contacts

Sierra D Kunkosi

(410) 350-3941

sierra.kunkoski@nih.gov

CONTACT

Dimitrios I Kapogiannis, M.D.

(667) 391-0063

kapogiannisd@mail.nih.gov

CONTACT